Materials Chemistry of Nanoultrasonic Biomedicine

• Published in: Advanced materials (Weinheim) Vol. 29; no. 10; pp. np - n/a
• Main Authors: Tang, Hailin, Zheng, Yuanyi, Chen, Yu
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.03.2017
• Subjects: Biocompatibility; cancer; Contrast agents; Contrast Media; Genes; Imaging; materials chemistry; Materials science; Microbubbles; Nanomaterials; nanomedicine; Nanostructure; Nanostructures; nanoultrasonic biomedicine; Releasing; Strategy; Theranostic Nanomedicine; Therapy; Toxicity; Ultrasonography; Ultrasound; ultrasound imaging; ultrasound therapy; Vaporization; ultrasound imaging; ultrasound therapy; nanomedicine; cancer; materials chemistry; nanoultrasonic biomedicine
• ISSN: 0935-9648; 1521-4095
• DOI: 10.1002/adma.201604105

As a special cross‐disciplinary research frontier, nanoultrasonic biomedicine refers to the design and synthesis of nanomaterials to solve some critical issues of ultrasound (US)‐based biomedicine. The concept of nanoultrasonic biomedicine can also overcome the drawbacks of traditional microbubbles and promote the generation of novel US‐based contrast agents or synergistic agents for US theranostics. Here, we discuss the recent developments of material chemistry in advancing the nanoultrasonic biomedicine for diverse US‐based bio‐applications. We initially introduce the design principles of novel nanoplatforms for serving the nanoultrasonic biomedicine, from the viewpoint of synthetic material chemistry. Based on these principles and diverse US‐based bio‐application backgrounds, the representative proof‐of‐concept paradigms on this topic are clarified in detail, including nanodroplet vaporization for intelligent/responsive US imaging, multifunctional nano‐contrast agents for US‐based multi‐modality imaging, activatable synergistic agents for US‐based therapy, US‐triggered on‐demand drug releasing, US‐enhanced gene transfection, US‐based synergistic therapy on combating the cancer and potential toxicity issue of screening various nanosystems suitable for nanoultrasonic biomedicine. It is highly expected that this novel nanoultrasonic biomedicine and corresponding high performance in US imaging and therapy can significantly promote the generation of new sub‐discipline of US‐based biomedicine by rationally integrating material chemistry and theranostic nanomedicine with clinical US‐based biomedicine. Recent developments in materials chemistry in advancing nanoultrasonic biomedicine for diverse novel ultrasound (US)‐based bio‐applications are discussed. First, the design principles/strategies of novel nanoplatforms for serving nanoultrasonic biomedicine are introduced. Then, representative proof‐of‐concept paradigms on this topic are clarified in detail.